225 related articles for article (PubMed ID: 27502273)
41. Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome.
Yue Y; Castrichini M; Srivastava U; Fabris F; Shah K; Li Z; Qu Y; El-Sherif N; Zhou Z; January C; Hussain MM; Jiang XC; Sobie EA; Wahren-Herlenius M; Chahine M; Capecchi PL; Laghi-Pasini F; Lazzerini PE; Boutjdir M
Circulation; 2015 Jul; 132(4):230-40. PubMed ID: 25995318
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of the HERG channel by droperidol depends on channel gating and involves the S6 residue F656.
Luo T; Luo A; Liu M; Liu X
Anesth Analg; 2008 Apr; 106(4):1161-70, table of contents. PubMed ID: 18349188
[TBL] [Abstract][Full Text] [Related]
43. Febrile temperature facilitates hERG/IKr degradation through an altered K(+) dependence.
Zhao Y; Wang T; Guo J; Yang T; Li W; Koichopolos J; Lamothe SM; Kang Y; Ma A; Zhang S
Heart Rhythm; 2016 Oct; 13(10):2004-11. PubMed ID: 27321242
[TBL] [Abstract][Full Text] [Related]
44. The hERG channel activator, RPR260243, enhances protective
Shi YP; Pang Z; Venkateshappa R; Gunawan M; Kemp J; Truong E; Chang C; Lin E; Shafaattalab S; Faizi S; Rayani K; Tibbits GF; Claydon VE; Claydon TW
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H251-H261. PubMed ID: 32559136
[TBL] [Abstract][Full Text] [Related]
45. Calpain activation by ROS mediates human ether-a-go-go-related gene protein degradation by intermittent hypoxia.
Wang N; Kang HS; Ahmmed G; Khan SA; Makarenko VV; Prabhakar NR; Nanduri J
Am J Physiol Cell Physiol; 2016 Mar; 310(5):C329-36. PubMed ID: 26659724
[TBL] [Abstract][Full Text] [Related]
46. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.
Sanguinetti MC; Jiang C; Curran ME; Keating MT
Cell; 1995 Apr; 81(2):299-307. PubMed ID: 7736582
[TBL] [Abstract][Full Text] [Related]
47. Cryo-EM Structure of the Open Human Ether-à-go-go-Related K
Wang W; MacKinnon R
Cell; 2017 Apr; 169(3):422-430.e10. PubMed ID: 28431243
[TBL] [Abstract][Full Text] [Related]
48. The Susceptibilities of Human Ether-à-Go-Go-Related Gene Channel with the G487R Mutation to Arrhythmogenic Factors.
Hisajima N; Hata Y; Kinoshita K; Fukushima T; Nishida N; Kano M; Tabata T
Biol Pharm Bull; 2015; 38(5):781-4. PubMed ID: 25947924
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation.
Aromolaran AS; Srivastava U; Alí A; Chahine M; Lazaro D; El-Sherif N; Capecchi PL; Laghi-Pasini F; Lazzerini PE; Boutjdir M
PLoS One; 2018; 13(12):e0208321. PubMed ID: 30521586
[TBL] [Abstract][Full Text] [Related]
50. Two mutations at different positions in the CNBH domain of the hERG channel accelerate deactivation and impair the interaction with the EAG domain.
Kume S; Shimomura T; Tateyama M; Kubo Y
J Physiol; 2018 Oct; 596(19):4629-4650. PubMed ID: 30086184
[TBL] [Abstract][Full Text] [Related]
51. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.
Mohammad S; Zhou Z; Gong Q; January CT
Am J Physiol; 1997 Nov; 273(5):H2534-8. PubMed ID: 9374794
[TBL] [Abstract][Full Text] [Related]
52. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current.
Witchel HJ; Hancox JC
Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):753-66. PubMed ID: 11022966
[TBL] [Abstract][Full Text] [Related]
53. A novel missense mutation causing a G487R substitution in the S2-S3 loop of human ether-à-go-go-related gene channel.
Kinoshita K; Yamaguchi Y; Nishide K; Kimoto K; Nonobe Y; Fujita A; Asano K; Tabata T; Mori H; Inoue H; Hata Y; Fukurotani K; Nishida N
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1246-53. PubMed ID: 22764740
[TBL] [Abstract][Full Text] [Related]
54. Screening for cardiac HERG potassium channel interacting proteins using the yeast two-hybrid technique.
Ma Q; Yu H; Lin J; Sun Y; Shen X; Ren L
Cell Biol Int; 2014 Feb; 38(2):239-45. PubMed ID: 24154981
[TBL] [Abstract][Full Text] [Related]
55. The influence of hERG1a and hERG1b isoforms on drug safety screening in iPSC-CMs.
Goversen B; Jonsson MK; van den Heuvel NH; Rijken R; Vos MA; van Veen TA; de Boer TP
Prog Biophys Mol Biol; 2019 Dec; 149():86-98. PubMed ID: 30826123
[TBL] [Abstract][Full Text] [Related]
56. Modulation of HERG K+ channels by chronic exposure to activators and inhibitors of PKA and PKC: actions independent of PKA and PKC phosphorylation.
Shu L; Zhang W; Su G; Zhang J; Liu C; Xu J
Cell Physiol Biochem; 2013; 32(6):1830-44. PubMed ID: 24356123
[TBL] [Abstract][Full Text] [Related]
57. Human ether-a-go-go-related (HERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects.
Zünkler BJ
Pharmacol Ther; 2006 Oct; 112(1):12-37. PubMed ID: 16647758
[TBL] [Abstract][Full Text] [Related]
58. Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking.
Wang L; Wible BA; Wan X; Ficker E
J Pharmacol Exp Ther; 2007 Feb; 320(2):525-34. PubMed ID: 17095614
[TBL] [Abstract][Full Text] [Related]
59. Probing the outer mouth structure of the HERG channel with peptide toxin footprinting and molecular modeling.
Tseng GN; Sonawane KD; Korolkova YV; Zhang M; Liu J; Grishin EV; Guy HR
Biophys J; 2007 May; 92(10):3524-40. PubMed ID: 17293393
[TBL] [Abstract][Full Text] [Related]
60. A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels.
Lin C; Cvetanovic I; Ke X; Ranade V; Somberg J
Am J Ther; 2005; 12(4):328-36. PubMed ID: 16041196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]